A multi-center, open-label, observational study to evaluate the efficacy and safety of LivaloZet® tablets in patients with dyslipidemia and metabolic syndrome: PIVOT study protocol - Poll - MDSpire

A multi-center, open-label, observational study to evaluate the efficacy and safety of LivaloZet® tablets in patients with dyslipidemia and metabolic syndrome: PIVOT study protocol

  • By

  • Kyong Hye Joung

  • Bon Jeong Ku

  • July 10, 2026

  • 0 min

Share

Original Source(s)

A multi-center, open-label, observational study to evaluate the efficacy and safety of LivaloZet® tablets in patients with dyslipidemia and metabolic syndrome: PIVOT study protocol

  • by Kyong Hye Joung, Bon Jeong Ku

  • July 10, 2026

Related Content

Investigating the association between low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and the risk of carotid artery plaque in patients with first-ever ischemic stroke based on different glucose metabolic conditions

Investigating association of triglycerides with hemodynamic parameters in patients with Low cardiovascular risk using 4D flow MRI

Association of serum 25-hydroxyvitamin D levels with indicators of target organ damage in patients with diabetes: a cross-sectional study